DK0596350T3 - Cyclopeptider - Google Patents
CyclopeptiderInfo
- Publication number
- DK0596350T3 DK0596350T3 DK93117204.3T DK93117204T DK0596350T3 DK 0596350 T3 DK0596350 T3 DK 0596350T3 DK 93117204 T DK93117204 T DK 93117204T DK 0596350 T3 DK0596350 T3 DK 0596350T3
- Authority
- DK
- Denmark
- Prior art keywords
- asp
- arg
- ala
- gly
- denotes
- Prior art date
Links
- 102000001189 Cyclic Peptides Human genes 0.000 title abstract 2
- 108010069514 Cyclic Peptides Proteins 0.000 title abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 102000006495 integrins Human genes 0.000 abstract 1
- 108010044426 integrins Proteins 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/52—Cyclic peptides containing at least one abnormal peptide link with only normal peptide links in the ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/75—Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Physical Education & Sports Medicine (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4237456A DE4237456A1 (de) | 1992-11-06 | 1992-11-06 | Cyclopeptide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0596350T3 true DK0596350T3 (da) | 1997-12-29 |
Family
ID=6472232
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK93117204.3T DK0596350T3 (da) | 1992-11-06 | 1993-10-23 | Cyclopeptider |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0596350B1 (cs) |
| JP (1) | JP3681764B2 (cs) |
| KR (1) | KR100238894B1 (cs) |
| CN (1) | CN1038751C (cs) |
| AT (1) | ATE154037T1 (cs) |
| AU (1) | AU666586B2 (cs) |
| CA (1) | CA2102447C (cs) |
| CZ (1) | CZ286170B6 (cs) |
| DE (2) | DE4237456A1 (cs) |
| DK (1) | DK0596350T3 (cs) |
| ES (1) | ES2105041T3 (cs) |
| GR (1) | GR3024550T3 (cs) |
| HU (1) | HU215600B (cs) |
| MX (1) | MX9306885A (cs) |
| NO (1) | NO309864B1 (cs) |
| PL (1) | PL177772B1 (cs) |
| RU (1) | RU2129563C1 (cs) |
| SK (1) | SK280597B6 (cs) |
| TW (1) | TW340849B (cs) |
| UA (1) | UA43822C2 (cs) |
| ZA (1) | ZA938281B (cs) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4237456A1 (de) * | 1992-11-06 | 1994-05-11 | Merck Patent Gmbh | Cyclopeptide |
| DE4310643A1 (de) * | 1993-04-01 | 1994-10-06 | Merck Patent Gmbh | Cyclische Adhäsionsinhibitoren |
| DE19538741A1 (de) * | 1995-10-18 | 1997-04-24 | Merck Patent Gmbh | Cyclopeptidderivate |
| DE19653036A1 (de) * | 1996-12-19 | 1998-06-25 | Merck Patent Gmbh | Cyclopeptidderivate |
| RU2255765C2 (ru) * | 2000-01-21 | 2005-07-10 | Чилдренз Хоспитал Лос-Анджелес | Способ ингибирования роста опухолей головного мозга с помощью отобранных антагонистов интегринов |
| ATE353918T1 (de) * | 2000-08-30 | 2007-03-15 | Hoffmann La Roche | Zyklische peptide als agonisten für den melanocortin-4-rezeptor |
| FR2814744B1 (fr) * | 2000-10-04 | 2002-11-29 | Commissariat Energie Atomique | Cyclopeptides, leur procede de preparation et leur utilisation comme inhibiteur ou activateur de l'angiogenese |
| EP3714885B1 (en) * | 2017-11-20 | 2024-07-31 | Novmetapharma Co., Ltd. | Composition for preventing, alleviating, or treating bone loss diseases, comprising cyclo(his-pro) (chp) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU892871A1 (ru) * | 1980-07-28 | 1983-09-15 | Ордена Трудового Красного Знамени Институт Органического Синтеза Ан Латвсср | Циклический аналог брадикинина,обладающий пролонгированным гипотензивным действием |
| US4816449A (en) * | 1984-08-09 | 1989-03-28 | Immunetech Pharmaceuticals | Immunotherapeutic anti-inflammatory peptide agents |
| GB8729802D0 (en) * | 1987-12-22 | 1988-02-03 | Beecham Group Plc | Novel compounds |
| DE4237456A1 (de) * | 1992-11-06 | 1994-05-11 | Merck Patent Gmbh | Cyclopeptide |
| US5516889A (en) * | 1993-06-21 | 1996-05-14 | University Technologies International, Inc. | Synthetic thrombin receptor peptides |
-
1992
- 1992-11-06 DE DE4237456A patent/DE4237456A1/de not_active Withdrawn
-
1993
- 1993-10-23 EP EP93117204A patent/EP0596350B1/de not_active Expired - Lifetime
- 1993-10-23 AT AT93117204T patent/ATE154037T1/de active
- 1993-10-23 ES ES93117204T patent/ES2105041T3/es not_active Expired - Lifetime
- 1993-10-23 DK DK93117204.3T patent/DK0596350T3/da active
- 1993-10-23 DE DE59306654T patent/DE59306654D1/de not_active Expired - Lifetime
- 1993-10-29 UA UA93002450A patent/UA43822C2/uk unknown
- 1993-10-29 KR KR1019930022666A patent/KR100238894B1/ko not_active Expired - Lifetime
- 1993-11-01 AU AU50399/93A patent/AU666586B2/en not_active Expired
- 1993-11-02 SK SK1217-93A patent/SK280597B6/sk not_active IP Right Cessation
- 1993-11-04 MX MX9306885A patent/MX9306885A/es unknown
- 1993-11-04 CA CA002102447A patent/CA2102447C/en not_active Expired - Lifetime
- 1993-11-04 CZ CZ19932352A patent/CZ286170B6/cs not_active IP Right Cessation
- 1993-11-04 TW TW082109233A patent/TW340849B/zh active
- 1993-11-04 PL PL93300935A patent/PL177772B1/pl unknown
- 1993-11-04 RU RU93050068A patent/RU2129563C1/ru active
- 1993-11-05 NO NO934003A patent/NO309864B1/no unknown
- 1993-11-05 CN CN93114224A patent/CN1038751C/zh not_active Expired - Lifetime
- 1993-11-05 JP JP30962593A patent/JP3681764B2/ja not_active Expired - Lifetime
- 1993-11-05 HU HU9303149A patent/HU215600B/hu unknown
- 1993-11-05 ZA ZA938281A patent/ZA938281B/xx unknown
-
1997
- 1997-08-27 GR GR970402189T patent/GR3024550T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2105041T3 (es) | 1997-10-16 |
| MX9306885A (es) | 1995-01-31 |
| TW340849B (en) | 1998-09-21 |
| CN1038751C (zh) | 1998-06-17 |
| CA2102447A1 (en) | 1994-05-07 |
| JP3681764B2 (ja) | 2005-08-10 |
| NO934003D0 (no) | 1993-11-05 |
| GR3024550T3 (en) | 1997-12-31 |
| HU215600B (hu) | 1999-01-28 |
| NO934003L (no) | 1994-05-09 |
| JPH0892282A (ja) | 1996-04-09 |
| RU2129563C1 (ru) | 1999-04-27 |
| DE4237456A1 (de) | 1994-05-11 |
| NO309864B1 (no) | 2001-04-09 |
| KR100238894B1 (ko) | 2000-01-15 |
| DE59306654D1 (de) | 1997-07-10 |
| HUT68321A (en) | 1995-06-28 |
| PL300935A1 (en) | 1994-05-16 |
| SK280597B6 (sk) | 2000-04-10 |
| ZA938281B (en) | 1994-06-07 |
| SK121793A3 (en) | 1995-06-07 |
| EP0596350B1 (de) | 1997-06-04 |
| CN1093090A (zh) | 1994-10-05 |
| CZ235293A3 (en) | 1994-07-13 |
| ATE154037T1 (de) | 1997-06-15 |
| AU5039993A (en) | 1994-05-19 |
| CA2102447C (en) | 2007-04-10 |
| CZ286170B6 (cs) | 2000-02-16 |
| KR940011479A (ko) | 1994-06-21 |
| PL177772B1 (pl) | 2000-01-31 |
| EP0596350A1 (de) | 1994-05-11 |
| AU666586B2 (en) | 1996-02-15 |
| UA43822C2 (uk) | 2002-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2144179T3 (es) | Inhibidores de adhesion ciclicos. | |
| NZ248377A (en) | Use of interleukin-1 beta protease and interleukin-1 beta protease inhibitors | |
| UA42747C2 (uk) | Похідні пептиду,фармацевтична композиція та спосіб стимулювання секреції гормону росту | |
| ATE211384T1 (de) | Verwendung von adenosinantagonisten zur vorbeugung und behandlung von pankreatitis und ulcera | |
| DE69725293D1 (de) | N-(2 oxoacetyl oder sulphonyl)-pyrrolidine/piperidine-2-carbonsäurederivate mit verbesserter multi-drug resistenz aktivität | |
| FI972086A7 (fi) | Parannetun monilääkeresistenssiaktiivisuuden omaavat uudet aminohappoj ohdokset | |
| IL152659A (en) | Liquid pharmaceutical compositions comprising a pegylated human erythropoietin protein and a multiple charged inorganic anion, in a pharmaceutically acceptable buffer | |
| ATE184792T1 (de) | 2-bromomelatonin zur behandlung von schlafstörungen | |
| UA41355C2 (uk) | Засіб для лікування нейро-сніду | |
| EP0705100A4 (en) | THERAPEUTIC SUBSTITUTED GUANIDINES | |
| DE69936381D1 (de) | Verwendung von einem protein kinase hemmer wie z.b. genistein bei der behandlung von diabetischer retinopathie | |
| CA2148194A1 (en) | Cyclopeptides of the formula i | |
| ES2106531T3 (es) | Compuestos de dibenzoxazepina substituidos en 2, 3, 4, 5, 6, 7, 8, 9 y/o 10, composiciones farmaceuticas y metodos de uso. | |
| ES2105041T3 (es) | Ciclopeptidos. | |
| IS2819B (is) | Viðloðunarsameindir í æðum og mótun á starfsemi@þeirra | |
| ATE111484T1 (de) | Verbindungen zur verhinderung von thrombose. | |
| DE3852935D1 (de) | Substituierte Alpha-Aminosäuren mit pharmazeutischer Aktivität. | |
| NO941151L (no) | Lineære adhesjonsinhibitorer | |
| ITRM910730A1 (it) | Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali. | |
| YU60199A (sh) | Nove soli bpc peptida sa organo-zaštitnom aktivnošću, postupak za njihovo dobijanje i njihova primena u terapiji | |
| EP0248231A3 (en) | Pharmacologically active peptides | |
| DK0613375T3 (da) | Farmaceutiske lysinholdige polypeptidpræparater og anvendelse deraf | |
| RU95120588A (ru) | Циклогексапептиды, их смеси, способ их получения и применения | |
| GR3015132T3 (en) | Novel ureas and thioureas, preparation thereof and application in therapy. | |
| DE59410340D1 (de) | Verwendung von Bradykinin-Antagonisten zur Behandlung von Viruserkrankungen |